search
x
Search
CDMO Services
TANVEX GLOBAL
TWSE (6541) 61.10| $ TWD
About
Overview
Mission & Values
Our Journey
Leadership
Employee Stories
Our mission is to make a positive contribution to humanity. We aim to improve the lives of people around the world by ensuring everyone has access to safe, effective, and affordable high-quality medicine — so they may live healthier days with their loved ones.
Products
Overview
Approved Products
Pipeline
Biosimilars
Pharmacovigilance
We believe health is for everyone. We are building a pathway to help as many people as possible get access to safe, effective, and affordable high-quality medicine. Our products continue the fight against deadly diseases such as neutropenia and breast cancer.
News & Media
Press Releases
Media Resources
Take a look at how we are impacting the world. Our news is your news as we continue our daily efforts to grant more patients access to safe, effective, and affordable high-quality medicine.
Resources
Brand to Biosimilar Database
We aim to be a respected partner to our customers. We are proud to offer comprehensive patient support services designed to help simplify and support patient access — for every Tanvex product. And, as a service to the healthcare professionals we serve, Tanvex provides a live brand to biosimilar database for product reference purposes.
Careers
Why Tanvex
Benefits
Job Opportunities
Come join our team. We are always looking for bright, motivated employees that share our vision to create a world where everyone has access to safe, effective, and affordable biopharmaceuticals.
Contact
GET IN TOUCH
Reach out to us. We are ready to listen and help.
News
Take a look at how we are impacting the world.
All News
By Year:
2024
2023
Sep 4, 2024
Tanvex Appoints Biopharma Industry Veteran Stephen Lam as CEO
Aug 27, 2024
Tanvex Forging Strategic Alliance with Bora Pharmaceuticals
Aug 19, 2024
Tanvex BioPharma USA, Inc. Achieves Dual U.S. Regulatory Milestones: FDA Approves Nypozi™ and FDA Accepts Biosimilar Biologics License Application for TX-05
Aug 1, 2024
FDA Accepts TX05 BLA Resubmission
Jul 8, 2024
TX05 BLA Resubmisson
1
2
3
NEXT
ALL NEWS
Javascript must be enabled for the correct page display
Javascript must be enabled for the correct page display
Javascript must be enabled for the correct page display
Javascript must be enabled for the correct page display
Javascript must be enabled for the correct page display
Javascript must be enabled for the correct page display
Javascript must be enabled for the correct page display
Javascript must be enabled for the correct page display
Javascript must be enabled for the correct page display
Javascript must be enabled for the correct page display